Joan spent her afternoon at a health fair and had
you are absolutely right because you said, In the United States vaccines preventable diseases has a substantial economic hardship on clinical trials, individuals, and healthcare providers. In 2022 the expenditure estimated nearly $27 billion annually for adult vaccine preventable diseases. I choose to review the cost effectiveness of vaccinating against Influenza. Influenza is a respiratory illness that affect the lungs, throat, and the nose. Influenza is a seasonal activity. According to a 2023 sciencedirect.com article, the cost-effectiveness of influenza vaccination is less than $95,000 per quality-adjusted life-year (QALY) for all subgroups, except for non-high-risk working-age adults. The vaccination is more favorable in certain scenarios, and the vaccination for higher risk subgroups can result in cost-effectiveness ratios (CERs) below $100,000 per QALY. Vaccinating healthy working adults can be cost-saving, with an average of $13.66 in savings per person vaccinated. However, this predicts a model of sensitivity to the influenza illness rate. In many situations, vaccination can actually generate net costs to society. Through vaccination programs there is there are potential savings of over $4.4 million on influenza-related hospitalizations. Also, $21.6 million can be save on productivity losses and work absenteeism for people being sick with influenza
******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."
